Setmelanotide
Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity
Rhythm · Phase 2 · Completed · Enrollment 213
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.